Sumathi Vaidhyanathaswamy

Suggest Changes
Learn More
Some reports have indicated increased rates of diabetes and increased prevalence of glucose and lipid abnormalities during treatment with second-generation antipsychotics, with most concern raised(More)
BACKGROUND Comparisons of diabetic potential, glucose related metabolic levels, and insulin resistance between olanzapine and risperidone have produced variable results in cross-sectional and(More)
  • 1